Bite the inside of your cheek, and the wound may vanish without a trace in a couple of days. A preclinical study co-led by ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

There are many diseases that mosquitoes can transmit, but HIV isn't one of them. Here's why, and what viruses you do need to watch out for depending on where you live.

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

Researchers revealed a 3.6 Å cryo-EM structure showing how HIV-1 Vif hijacks the host’s CUL5 E3 ligase to degrade APOBEC3H, a viral defense protein. The findings shed light on HIV’s immune ...